samedan logo

 
 
spacer
home > pmps > winter 2008 > bursting the bubble
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bursting the Bubble

Bubble-free filling can enhance the dosing accuracy and efficiency of a syringe; Shawn D Kinney, Andrea Wagner and Christian Phillips at HCM explain

Prefilled syringes have gone a long way towards improving dosing accuracy and decreasing waste relative to vials. With their ease of use and reduced overfill requirements, prefilled syringes significantly decrease the risk of dosing errors and provide the potential for an increase of up to 23 per cent in product dose yield compared with a vial (1).

Two recent studies suggest that the dosing advantages of a prefilled syringe can be enhanced even further by decreasing the size of the gas bubble inside. A gas bubble is not intrinsic to a syringe but is a byproduct of the filling process. These studies show that reducing or eliminating the bubble inside a prefilled syringe offers added assurance that the exact deliverable dose will be expelled regardless of needle orientation.

FILLING AND STOPPERING PREFILLED SYRINGES

Until recently, there were two methods for filling and stoppering syringes: online filling and online stopper (piston) placement, and online filling followed by offline vacuum stoppering. Then, a third method was introduced by filling equipment manufacturers that allows for online vacuum filling and online vacuum stoppering. This was initially designed to enhance the filling of viscous products and reduce handling of the filled syringe prior to vacuum stoppering. More recently still, a fourth method for filling prefilled syringes was developed which uses vacuum filling and online vacuum stoppering along with proprietary technology to entirely eliminate the bubble inside a syringe. Reducing or eliminating the bubble in a prefilled syringe can have a significant impact on dosing accuracy, quantity and ease.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Dr Shawn D Kinney, PhD, is the Founder and President of Hyaluron Contract Manufacturing (HCM), located in Burlington, MA. Prior to starting HCM in 1999, Shawn was employed by Anika Therapeutics, Wyeth-Ayerst and Millipore, where he gained over 20 years of experience in the development of sterile formulation and filling processes including viscous and difficult-to-fill products. Shawn holds a Bachelor of Science and a PhD in Chemistry from the University of Massachusetts, as well as a Masters in Medicinal Chemistry from Northeastern University.

Dr Andrea Wagner, PhD, is the Vice President of Business Development at Hyaluron Contract Manufacturing (HCM), a position she has held for six years. Prior to joining HCM, Andrea was employed by the New Jersey Institute of Technology and Niton Corporation, in the capacities of Senior Scientist and Business Development Manager, respectively. Andrea holds a PhD in Toxicology and a Masters in Analytical Chemistry.

Christian W Phillips is the Senior Manager of Process Engineering at HCM. Christian has 14 years of experience in R&D, process development, tech transfer and manufacturing environments suited for the introduction of novel biotherapeutics and generics, including fill/finish applications. Prior to HCM, Christian was employed by TransKaryotic Therapies (now Shire HGS). He holds a BS in Biology from St Michaels College and is the co-inventor of HCM’s Bubble-free FillingTM technology.

spacer
Dr Shawn D Kinney
spacer
spacer
spacer
Dr Andrea Wagner
spacer
spacer
spacer
Christian W Phillips
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Colorcon, Inc. Launches Nutrafinish® Label Friendly Tablet Coatings for Nutritional Supplements Market

Harleysville, Pennsylvania, USA, 23rd February 2021 - Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces the expansion of its Nutrafinish® Film Coatings portfolio to include Label Friendly and TiO2-Free coating products for the nutritional and dietary supplements market.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement